PTC Therapeutics removes redactions from $300M credit agreement, disclosing Events of Default terms

PTC THERAPEUTICS, INC.

Filed unredacted Credit Agreement dated Oct 27, 2022; initial term loan facility of $300M and delayed draw up to $150M.
Company no longer seeks confidential treatment for Section 8.01 (Events of Default) and other provisions.
Credit agreement also contemplates up to $500M in incremental investments subject to lender consent.
Lenders include Blackstone-related entities; interest rate is Adjusted Term SOFR + 7.25%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.